Is now the time to buy Medifast? Find out by accessing our full research report, it’s free. ・Revenue: $119 million vs analyst estimates of $114.3 million (37.7% year-on-year decline, ...

Department now expects that the specialty retailer will post earnings of ($0.07) per share for the quarter, up from their previous forecast of ($0.10). The consensus estimate for Medifast’s ...

We take a look at earnings estimates for some clues. What a brutal six months it’s been for Medifast. The stock has dropped 20.6% and now trades at $19.84, rattling many shareholders.

CEO Dan Chard highlighted that 2024 was a transformative year for Medifast due to the increasing adoption of GLP-1 weight loss medications. The company is adapting to these market shifts by ...

Medifast beat analysts’ revenue expectations ... The US Central Band is now cutting rates. That, plus the election of Donald Trump in November 2024, sent markets even higher, and while some ...

Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on MED: Medifast NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

It is now my pleasure to introduce Steven Zenker, Vice President, Investor Relations. Please go ahead. Good afternoon and welcome to Medifast's Fourth Quarter and Full Year 2024 Earnings ...

BALTIMORE (AP) — BALTIMORE (AP) — Medifast Inc. (MED) on Tuesday reported profit of $800,000 in its fourth quarter. On a per-share basis, the Baltimore-based company said it had profit of 7 cents.

Department now expects that the specialty retailer will post earnings per share of $0.24 for the quarter, down from their previous estimate of $0.29. The consensus estimate for Medifast’s ...